Shock recovery: testing blood flow with ultrasound
Part of Heart & circulation clinical trials.
This study uses ultrasound to measure blood flow in the aorta (the main artery from the heart) to help doctors decide if patients in the intensive care unit need more fluids. It is for people whose shock is not getting better after the first 6 hours of treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are in the medical ICU at Ankara University Hospital
- You have been diagnosed with shock
- Your shock is not improving after 6 hours of treatment
- You are expected to stay in the ICU for at least 48 hours
- You or your family can sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies different ways to measure how much extra fluid your body can handle when you are in shock. The goal is to see which method works best and helps doctors make better decisions about fluid treatment.
This study checks whether a specific heart ultrasound measurement can help doctors decide if you will benefit from extra fluid during early emergency treatment for shock. It may help avoid unnecessary fluids and support faster, safer decision-making.
This study uses ultrasound to measure how much fluid shocked trauma patients need. It could help doctors give the right amount of fluids in the emergency room and ICU.
This trial compares using ultrasound of the large belly vein (IVC) versus a standard pressure measurement to see if you need more fluids when in shock. It aims to find a quicker, safer way to guide treatment in the emergency room.
This trial is testing a new system called Argos to see if it can measure how much blood your heart pumps more easily than current methods. It is for patients already in the ICU who need a quick change in fluids or blood pressure medicine.
This study tests a method called tissue perfusion pressure to see if it can accurately predict whether a patient in shock will benefit from getting more fluids. It aims to help doctors make better decisions about fluid treatment in the ICU.
Hear when a new Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.